loadpatents
name:-0.03265905380249
name:-0.025574922561646
name:-0.36908006668091
Li; Derun Patent Filings

Li; Derun

Patent Applications and Registrations

Patent applications and USPTO patent grants for Li; Derun.The latest application filed is for "natriuretic peptide receptor a agonists useful for the treatment of cardiometabolic diseases, kidney disease and diabetes".

Company Profile
21.24.33
  • Li; Derun - West Roxbury MA
  • Li; Derun - Brighton MA
  • LI; Derun - Roxbury MA
  • Li; Derun - Concord CA
  • Li; Derun - Scotch Plains NJ
  • LI; Derun - Boston MA US
  • Li; Derun - Roselle Park NJ
  • LI; Derun - Rahway NJ US
  • Li; Derun - Somerville MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Natriuretic Peptide Receptor A Agonists Useful For The Treatment Of Cardiometabolic Diseases, Kidney Disease And Diabetes
App 20220281886 - Bennett; Frank ;   et al.
2022-09-08
Natriuretic Peptide Receptor A Agonists Useful For The Treatment Of Cardiometabolic Diseases, Kidney Disease And Diabetes
App 20220273669 - Hong; Qingmei ;   et al.
2022-09-01
1-pyrazolyl, 5-, 6- Disubstituted Indazole Derivatives As Lrrk2 Inhibitors, Pharmaceutical Compositions, And Uses Thereof
App 20220259188 - Zhou; Hua ;   et al.
2022-08-18
Substituted cyclobutylbenzene compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
Grant 11,319,283 - McGowan , et al. May 3, 2
2022-05-03
Arginase inhibitors and methods of use
Grant 11,274,111 - Achab , et al. March 15, 2
2022-03-15
Arginase Inhibitors And Methods Of Use
App 20220056051 - Achab; Abdelghani Abe ;   et al.
2022-02-24
Novel Substituted Tricyclic Compounds As Indoleamine 2,3-dioxygenase Inhibitors
App 20210403469 - Han; Yongxin ;   et al.
2021-12-30
Substituted phenyl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
Grant 11,208,407 - Zhou , et al. December 28, 2
2021-12-28
N-heteroaryl Indazole Derivatives As Lrrk2 Inhibitors, Pharmaceutical Compositions, And Uses Thereof
App 20210395236 - SIMOV; Vladimir ;   et al.
2021-12-23
Systems And Methods For Diffractive Coherent Laser Combining
App 20210341764 - Du; Qiang ;   et al.
2021-11-04
Novel Substituted Biaryl Compounds As Indoleamine 2,3-dioxygenase (ido) Inhibitors
App 20210317091 - Han; Yongxin ;   et al.
2021-10-14
Substituted cyclobutylpyridine and cyclobutylpyrimidine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
Grant 11,111,232 - White , et al. September 7, 2
2021-09-07
Novel Substituted Tetrahydroquinolin Compounds As Indoleamine 2,3-dioxygenase (ido) Inhibitors
App 20210179607 - Deng; Yongqi ;   et al.
2021-06-17
Substituted N'-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase IDO inhibitors
Grant 11,034,661 - Guo , et al. June 15, 2
2021-06-15
Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors
Grant 11,028,092 - Arasappan , et al. June 8, 2
2021-06-08
Arginase Inhibitors And Methods Of Use
App 20210163505 - Achab; Abdelghani Abe ;   et al.
2021-06-03
Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
Grant 10,995,085 - Han , et al. May 4, 2
2021-05-04
Substituted n'-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
Grant 10,988,487 - Liu , et al. April 27, 2
2021-04-27
Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors
Grant 10,934,294 - Arasappan , et al. March 2, 2
2021-03-02
Substituted sulfoximine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
Grant 10,927,086 - Liu , et al. February 23, 2
2021-02-23
Arginase Inhibitors And Methods Of Use
App 20210040127 - Achab; Abdelghani Abe ;   et al.
2021-02-11
Novel Substituted Cyclobutylpyridine And Cyclobutylpyrimidine Compounds As Indoleamine 2,3-dioxygenase (ido) Inhibitors
App 20200290996 - White; Catherine M. ;   et al.
2020-09-17
Novel Substituted Cyclobutylbenzene Compounds As Indoleamine 2,3-dioxygenase (ido) Inhibitors
App 20200277252 - McGowan; Meredeth Ann ;   et al.
2020-09-03
Novel Substituted N'-hydroxycarbamimidoyl-1,2,5-oxadiazole Compounds As Indoleamine 2,3-dioxygenase (ido) Inhibitors
App 20200231606 - Liu; Kun ;   et al.
2020-07-23
Novel Substituted Biaryl Compounds As Indoleamine 2,3-dioxygenase (ido) Inhibitors
App 20200216425 - Han; Yongxin ;   et al.
2020-07-09
Novel Substituted Phenyl Compounds As Indoleamine 2,3-dioxygenase (ido) Inhibitors
App 20200216443 - Zhou; Hua ;   et al.
2020-07-09
Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
Grant 10,647,705 - Han , et al.
2020-05-12
Pyrazolopyrimidine Pde9 Inhibitors
App 20200140445 - ARASAPPAN; Ashok ;   et al.
2020-05-07
Novel Substituted N'-hydroxycarbamimidoyl-1,2,5-oxadiazole Compounds As Indoleamine 2,3-dioxygenase Ido Inhibitors
App 20200102278 - Guo; Liangqin ;   et al.
2020-04-02
Novel Substituted Sulfoximine Compounds As Indoleamine 2,3-dioxygenase (ido) Inhibitors
App 20200095212 - Liu; Kun ;   et al.
2020-03-26
Compound useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolc disease
Grant 10,414,774 - Cumming , et al. Sept
2019-09-17
Compounds useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolic disease
Grant 10,414,775 - Caldwell , et al. Sept
2019-09-17
Compounds Useful For Altering The Levels Of Bile Acids For The Treatment Of Diabetes And Cardiometabolc Disease
App 20190218224 - Caldwell; John P. ;   et al.
2019-07-18
Compounds Useful For Altering The Levels Of Bile Acids For The Treatment Of Diabetes And Cardiometabolc Disease
App 20190218223 - Cumming; Jared N. ;   et al.
2019-07-18
Novel Substituted Biaryl Compounds As Indoleamine 2,3-dioxygenase (ido) Inhibitors
App 20190144433 - Han; Yongxin ;   et al.
2019-05-16
Pyrazolopyrimidine Pde9 Inhibitors
App 20180354955 - ARASAPPAN; Ashok ;   et al.
2018-12-13
Factor IXa inhibitors
Grant 9,695,198 - Smith , et al. July 4, 2
2017-07-04
Synthesis of Tetracyclines and intermediates thereto
Grant 9,688,644 - Myers , et al. June 27, 2
2017-06-27
Antidiabetic tricyclic compounds
Grant 9,527,875 - Hagmann , et al. December 27, 2
2016-12-27
Synthesis Of Tetracyclines And Intermediates Thereto
App 20160002183 - Myers; Andrew G. ;   et al.
2016-01-07
Factor IXa Inhibitors
App 20150368269 - Smith; Cameron James ;   et al.
2015-12-24
Antidiabetic Tricyclic Compounds
App 20150191495 - Hagmann; William K. ;   et al.
2015-07-09
Synthesis of tetracyclines and intermediates thereto
Grant 9,073,829 - Myers , et al. July 7, 2
2015-07-07
Chiral thiourea compounds and process for enantioselective reduction of ketones
Grant 8,334,405 - Li , et al. December 18, 2
2012-12-18
Synthesis Of Tetracyclines And Intermediates Thereto
App 20120115818 - Myers; Andrew G. ;   et al.
2012-05-10
Chiral thiourea compounds and process for enantioselective reduction of ketones
App 20090253919 - Li; Derun ;   et al.
2009-10-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed